In the Zone: flow cytometry for cell and gene therapies
As a bioanalytical method capable of detecting and measuring the physical and chemical properties of a population of cells, traditional flow cytometry has remained a mainstay of the bioanalytical laboratory for gene-mediated cell therapy development. Whether for utilization in target or lead development and validation, preclinical studies or clinical studies, flow cytometry offers rapid multiparametric analysis of single or populations of cells and robust data throughout the different stages of therapeutic development.
INFOGRAPHIC
Infographic: exploring the benefits of flow cytometry for CGT development – 
In this infographic we explore the benefits of flow cytometry through each stage of cell and gene therapy development, from target and lead development and validation, preclinical studies and clinical studies.
PODCAST
Flow cytometry for the development of CGT assays: an interview with Richard Cuthbert – In this podcast interview, Richard Cuthbert, Global Commercialization Product Manager Flow and Antibody Business at Bio-Rad (UK), explores the utilization of flow cytometry for cell and gene therapy (CGT) assay development
RESOURCES
Flow cytometry and pharmacokinetics
The challenges of cell and gene therapy products with Sanyogitta Puri
Two-step protocol for preparing adherent cells for high-throughput flow cytometry
[Video by Kristian Baycroft-Willmott]
In association with:
